Bacterial vaginosis affects one third of reproductive-aged women, and recurrence is common. Evidence of sexual exchange of ...

Recommendation based on the findings from the Phase 3 QUASAR programme in ulcerative colitis 1. Beerse, Belgium (28 February 2025) - Johnson & Johnson today announced that the Com ...

The CDC says most adults born in 1957 or later should get at least one dose of the MMR vaccine. All women of childbearing age should get the MMR vaccine unless they're pregnant, have proof of ...

Additionally, Eli Lilly is also making strides in other areas, like the recent approval of Omvoh for Crohn’s disease and the potential of Ebglyss for atopic dermatitis. These moves reflect Eli Lilly’s ...

Lilly launches additional Zepbound vial doses and offers new savings for self-pay patients ... end-end-digital-healthcare-experience-through 4. FDA approves Lilly's Omvoh (mirikizumab-mrkz) for ...

Eli Lilly said Tuesday that it will offer more doses of its obesity drug Zepbound in vials and lower the prices of the doses it already sells, as the pharma giant seeks to draw patients away from ...

BridgeBio Pharma has received European approval for a drug that treats cardiomyopathy stemming from a rare metabolic condition, strengthening the biotech’s position to take market share from the ...

That’s called “background” radiation. Experts use the phrase “effective dose” to describe how much radiation your body absorbs. Different types of tissue are more sensitive than others.

J&J’s competition does have the edge in certain IBD indications, however, with both Omvoh and Skyrizi having been granted ... the company’s Phase IIb/III Quasar study (NCT04033445), a dose-ranging ...

"What we found is that if someone is taking a stimulant and an opioid at the same time, they're generally taking a high dose of the opioid," he said. "And if the patient in this study population ...